Psychedelics have been used as treatments for mental health conditions for decades, but most have undesirable off-target. A new wave of tailored psychedelic compounds could pave the way for psychedelic therapies with fewer side effects. This compound, called VCU-1012, is so named because it was created at Virginia Commonwealth University (VCU). Written & Hosted by Ben Rein Produced & Edited by Maren Hunsberger Serotonin images from Aqeela Imamdin & Emiel van der Vorst. (2023). Exploring the Role of Serotonin as an Immune Modulatory Component in Cardiovascular Diseases. International Journal of Molecular Sciences. Stock footage: Getty / kelmedia / Ekaterina Goncharova Supervising Producer: Shamini Bundell From Younkin, J., et al. (2026). Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects. Science Signaling. https://10.1126/scisignal.adw605 @Nature
11.52% ERengagement of this clip — below the author's average (14.98%)
top 100%outperforms 0% of the author's clips
0%of the author's average views
